Figure 9. Establishment and assessment of the nomogram. (A) Univariate Cox analysis of risk scores and clinical characteristics. (B) Multifactorial Cox analysis of risk scores and clinical characteristics. (C) Construction of the nomogram. (D) The calibration curve of the nomogram. (E) DCA diagram. Enrichment of tumor-related pathways (F) and immune-related pathways (G) in the high-risk group.